Epicardial Adipose Tissue Thickness and Body Mass Index as Early Predictors of Thrombolysis Success in Patients with Elevated ST-Segment Myocardial Infarct

Document Type : Original Article

Authors

1 Department of Cardiology, CMN “20 de Noviembre”, ISSSTE, Mexico City, Mexico.

2 Department of Cellular and Tissue Biology, Faculty of Medicine, UNAM, Mexico City, Mexico.

3 Department of Cardiovascular Surgery, CMN “20 de Noviembre”, ISSSTE, Mexico City, Mexico.

Abstract

Introduction:  Early intravenous thrombolysis in elevated ST-segment myocardial infarcted patients reduces morbidity/mortality, however in non-responsive patients, it can delay the endovascular revascularization process. Increased epicardial adipose tissue thickness (EATT) is associated with adverse cardiovascular events and artery patency. Our aim was to evaluate if EATT influences the response to thrombolytic therapy in patients with acute myocardial infarction.
Material and Method: This prospective cohort study included fifty patients (40 males and 10 females) with a mean age of 60 ± 9 years old and a presumptive acute myocardial infarct diagnosis. All the patients were hospitalized in the intensive care coronary unit. According to ESC and ACC guidelines, the diagnosis of acute myocardial infarct was corroborated. Patients were treated with 0.5 mg/kg IV bolus of the specific recombinant plasminogen activator Tenecteplase. The transthoracic 2-dimensional echocardiography was performed to recognize EAT from the parasternal long-axis view.
Results: The time lapse between initial symptoms and thrombolysis was 227±43 mm. Sixteen patients showed positive reperfusion less than 90 minutes after thrombolysis, and the remaining 34 required a percutaneous coronary intervention. The mean EATT value of thrombolysis-responding patients was 2.4 ± 0.4 mm vs 6.5 ± 0.6 mm of the non-responders (p= 0.001). In responders, the percentage of  body mass index  (BMI)  was 26.1 ± 0.02% vs 29.1± 0.02% (kg/m2)  in non-responders (p= 0.001). Interestingly, an EATT value > 2.5 mm and a BMI > 26 showed a highly significant inverse correlation response to thrombolysis and positive myocardial reperfusion (r = -0.71 y 0.55, p = 0.001 respectively). These values had a prognostic sensitivity of 93% and specificity of 84%.
Conclusion: EATT and BMI could be usefull serve as early decision indicators to determine the possible response to thrombolysis and positive myocardial reperfusion in acute myocardial infarcted patients, although there is a need for studies with larger sample sizes.

Keywords


  1. Iacobellis G, Bianco AC. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends in Endocrinology & Metabolism. 2011 Nov 1;22(11):450-7..
  2. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003 Nov 18;108(20):2460-6..
  3. Iacobellis G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nature Reviews Endocrinology. 2015 Jun;11(6):363-71..
  4. Villasante Fricke AC, Iacobellis G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. International journal of molecular sciences. 2019 Nov 28;20(23):5989.
  5. Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY, et al. Depot-specific overexpression of proinflammatory, redox, endothelial cell, and angiogenic genes in epicardial fat adjacent to severe stable coronary atherosclerosis. Metabolic syndrome and related disorders. 2011 Dec 1;9(6):433-9.
  6. Gać P, Macek P, Poręba M, Kornafel-Flak O, Mazur G, Poręba R. Thickness of epicardial and pericoronary adipose tissue measured using 128-slice MSCT as predictors for risk of significant coronary artery diseases. Irish Journal of Medical Science (1971-). 2021 May;190:555-66..
  7. Eroğlu S. How do we measure epicardial adipose tissue thickness by transthoracic echocardiography?. Anatolian journal of cardiology. 2015 May;15(5):416.
  8. Shao C, Wang J, Tian J, Tang YD. Coronary artery disease: from mechanism to clinical practice. Coronary Artery Disease: Therapeutics and Drug Discovery. 2020:1-36.
  9. Bhaskar S, Stanwell P, Cordato D, Attia J, Levi C. Reperfusion therapy in acute ischemic stroke: dawn of a new era?. BMC neurology. 2018 Dec;18:1-26.
  10. Akbas EM, Hamur H, Demirtas L, Bakirci EM, Ozcicek A, Ozcicek F, et al. Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus. Diabetology & metabolic syndrome. 2014 Dec;6(1):1-8.
  11. Yılmaz S, Sen F, Temizhan A. Epicardial Adipose Tissue Thickness, Is It a Reason or a Consequence?. Angiology. 2016 Mar;67(3):293-..
  12. Lee YY, Tee MH, Zurkurnai Y, Than W, Sapawi M, Suhairi I. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria. Singapore medical journal. 2008 Apr 1;49(4):304.
  13. Gorter PM, van Lindert AS, de Vos AM, Meijs MF, van der Graaf Y, Doevendans PA, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis. 2008 Apr 1;197(2):896-903.
  14. Sarı M, Çakmak EÖ, Karagöz A, Yılmaz F, Aytürk M, Fidan S, et al. Subacute lower extremity arterial thrombosis; early outcomes of catheter directed thrombolysis with alteplase and importance of malnutrition assessed by CONUT score. Turk Kardiyol Dern Ars. 2021 Oct 1;49(7):568-78.
  15. Chen YC, Lee WH, Lee MK, Hsu PC, Tsai WC, Chu CY, et al. Epicardial adipose tissue thickness is not associated with adverse cardiovascular events in patients undergoing haemodialysis. Scientific Reports. 2020 Apr 14;10(1):6281.
  16. Nerlekar N, Thakur U, Lin A, Koh JQ, Potter E, Liu D, et al. The Natural history of Epicardial Adipose Tissue Volume and Attenuation: A long-term prospective cohort follow-up study. Scientific reports. 2020 Apr 28;10(1):7109.
  17. Sen F, Yilmaz S, Balci KG, Gül M, Balci MM, Akboga MK, et al. The relationship between epicardial adipose tissue thickness and infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2016 Mar;67(3):281-6.
  18. Mortara A, Specchia G, La Rovere MT, Bigger Jr JT, Marcus FI, Camm JA, et al. Patency of infarct-related artery: effect of restoration of anterograde flow on vagal reflexes. Circulation. 1996 Mar 15;93(6):1114-22.
  19. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018 Nov 13;138(20):e618-51.
  20. Domanski MJ. Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting. American Heart Journal. 2012 Nov 1;164(5):636-7.
  21. Writing Committee Members, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022 Jan 18;79(2):197-215.
  22. Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. Journal of the American Society of Echocardiography. 2009 Dec 1;22(12):1311-9.
  23. Konwerski M, Gąsecka A, Opolski G, Grabowski M, Mazurek T. Role of epicardial adipose tissue in cardiovascular diseases: a review. Biology. 2022 Feb 23;11(3):355.
  24. Nagy E, Jermendy AL, Merkely B, Maurovich-Horvat P. Clinical importance of epicardial adipose tissue. Archives of Medical Science. 2017 Jun 22;13(4):864-74.
  25. Mahabadi AA, Berg MH, Lehmann N, Kälsch H, Bauer M, Kara K, et al. Association of epicardial fat with cardiovascular risk factors and incident myocardial infarction in the general population: the Heinz Nixdorf Recall Study. Journal of the American College of Cardiology. 2013 Apr 2;61(13):1388-95.
  26. Cabrera-Rego JO, Iacobellis G, Castillo-Herrera JA, Valiente-Mustelier J, Gandarilla-Sarmientos JC, Marín-Juliá SM, et al. Epicardial fat thickness correlates with carotid intima-media thickness, arterial stiffness, and cardiac geometry in children and adolescents. Pediatric cardiology. 2014 Mar;35:450-6.
  27. Bertaso AG, Bertol D, Duncan BB, Foppa M. Epicardial fat: definition, measurements and systematic review of main outcomes. Arquivos brasileiros de cardiologia. 2013;101:e18-28.
  28. Fox CS, Gona P, Hoffmann U, Porter SA, Salton CJ, Massaro JM, et al. Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study. Circulation. 2009 Mar 31;119(12):1586-91.
  29. Aitken-Buck HM, Moharram M, Babakr AA, Reijers R, Van Hout I, Fomison-Nurse IC, et al. Relationship between epicardial adipose tissue thickness and epicardial adipocyte size with increasing body mass index. Adipocyte. 2019 Jan 2;8(1):412-20.
  30. Raman P, Khanal S. Leptin in atherosclerosis: focus on macrophages, endothelial and smooth muscle cells. International Journal of Molecular Sciences. 2021 May 21;22(11):5446.
  31. Mahmoud I, Dykun I, Kärner L, Hendricks S, Totzeck M, Al-Rashid F, et al. Epicardial adipose tissue differentiates in patients with and without coronary microvascular dysfunction. International Journal of Obesity. 2021 Sep;45(9):2058-63.
  32. Killip III T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. The American journal of cardiology. 1967 Oct 1;20(4):457-64.
  33. Hashmi KA, Adnan F, Ahmed O, Yaqeen SR, Ali J, Irfan M, et al. Risk assessment of patients after ST-segment elevation myocardial infarction by Killip Classification: an institutional experience. Cureus. 2020 Dec 21;12(12).
  34. Vicent L, Velásquez-Rodríguez J, Valero-Masa MJ, Díez-Delhoyo F, González-Saldívar H, Bruña V, et al. Predictors of high Killip class after ST segment elevation myocardial infarction in the era of primary reperfusion. International Journal of Cardiology. 2017 Dec 1;248:46-50.
  35. Kosuge M, Kimura K, Kojima S, Sakamoto T, Ishihara M, Asada Y, et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation acute myocardial infarction. Circulation Journal. 2007;72(4):521-5.